Published in Adv Immunol on January 01, 1994
Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci U S A (1995) 1.97
Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med (1996) 1.67
Eosinophilic gastroenteritis: a review. J Gastroenterol (2008) 1.63
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Respir Med (2014) 1.37
Eosinophils in innate immunity: an evolving story. Cell Tissue Res (2010) 1.34
Evolutionary divergence and functions of the human interleukin (IL) gene family. Hum Genomics (2010) 1.15
Interleukin-5 and IL-5 receptor in health and diseases. Proc Jpn Acad Ser B Phys Biol Sci (2011) 1.00
A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5. Proc Natl Acad Sci U S A (1997) 1.00
CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain: synergistic effects with interleukin 5. Proc Natl Acad Sci U S A (1995) 0.93
Endogenous IL-10 regulates IFN-gamma and IL-5 cytokine production and the granulomatous response in Schistosomiasis mansoni-infected mice. Immunology (1998) 0.91
Elevated IL-5 levels in pleural fluid of patients with paragonimiasis westermani. Clin Exp Immunol (2001) 0.88
Schistosomiasis: progress and problems. World J Gastroenterol (2000) 0.84
Elevated levels of thymus and activation-regulated chemokine (TARC) in pleural effusion samples from patients infested with Paragonimus westermani. Clin Exp Immunol (2002) 0.81
The clinical significance of eosinophils in the amniotic fluid in preterm labor. J Matern Fetal Neonatal Med (2010) 0.79
Benralizumab: a unique IL-5 inhibitor for severe asthma. J Asthma Allergy (2016) 0.78
Functional dissection of the cytoplasmic subregions of the interleukin-5 receptor alpha chain in growth and immunoglobulin G1 switch recombination of B cells. Immunology (2001) 0.78
Eosinophil and IgE responses of IL-5 transgenic mice experimentally infected with Nippostrongylus brasiliensis. Korean J Parasitol (1999) 0.75
Splicing Regulation of Pro-Inflammatory Cytokines and Chemokines: At the Interface of the Neuroendocrine and Immune Systems. Biomolecules (2015) 0.75
TRIF Deficiency does not Affect Severity of Ovalbumin-induced Airway Inflammation in Mice. Immune Netw (2014) 0.75
Bringing Stability to the Chronic Obstructive Pulmonary Disease Patient: Clinical and Pharmacological Considerations for Frequent Exacerbators. Drugs (2017) 0.75
Population Pharmacokinetics and Pharmacodynamics of Benralizumab in Healthy Volunteers and Patients With Asthma. CPT Pharmacometrics Syst Pharmacol (2017) 0.75
Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells (1999) 3.69
A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice. Dev Biol (1999) 3.11
Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5. Gene (1989) 3.00
Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med (1989) 2.12
Atomic-level observation of disclination dipoles in mechanically milled, nanocrystalline Fe. Science (2002) 2.07
Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J Exp Med (1991) 1.89
Molecular cloning and expression of the murine interleukin-5 receptor. EMBO J (1990) 1.85
Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J Exp Med (1994) 1.83
BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12). J Immunol (1985) 1.72
Dominant effector genetics in mammalian cells. Nat Genet (2001) 1.68
Differential signaling by lymphocyte antigen receptors. Annu Rev Immunol (1997) 1.54
Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. Immunity (1996) 1.40
Distribution of IL-5 receptor-positive B cells. Expression of IL-5 receptor on Ly-1(CD5)+ B cells. J Immunol (1990) 1.36
Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication. J Exp Med (1988) 1.33
Molecular cloning and expression of the human interleukin 5 receptor. J Exp Med (1992) 1.31
IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med (1994) 1.30
The role of interleukin-5 in protective immunity to Strongyloides venezuelensis infection in mice. Immunology (1991) 1.26
Characterization of high-affinity receptors for interleukin 5 on interleukin 5-dependent cell lines. Proc Natl Acad Sci U S A (1989) 1.22
T cells from eosinophilic patients produce interleukin-5 with interleukin-2 stimulation. Blood (1989) 1.20
Characterization of the murine interleukin 5 receptor by using a monoclonal antibody. Int Immunol (1990) 1.18
A distinct pathway of cell-mediated apoptosis initiated by granulysin. J Immunol (2001) 1.11
Interleukin-5. Curr Opin Immunol (1992) 1.10
Interleukin-5 induces maturation but not class switching of surface IgA-positive B cells into IgA-secreting cells. Immunology (1989) 1.10
Establishment of IL-5-dependent early B cell lines by long-term bone marrow cultures. Growth Factors (1989) 1.08
An IFN-gamma-dependent pathway plays a critical role in the pathogenesis of murine immunodeficiency syndrome induced by LP-BM5 murine leukemia virus. Int Immunol (1994) 1.03
Stable, stoichiometric delivery of diverse protein functions. J Biochem Biophys Methods (2004) 1.01
Interleukin 5 and interleukin 3 induce serine and tyrosine phosphorylations of several cellular proteins in an interleukin 5-dependent cell line. Biochem Biophys Res Commun (1990) 1.00
Identification and characterization of a transcriptional regulator for the lck proximal promoter. J Biol Chem (2001) 0.97
Monitoring drug noncompliance in epileptic patients: assessing phenobarbital plasma levels. Ther Drug Monit (1985) 0.97
Molecular cloning of the mouse APS as a member of the Lnk family adaptor proteins. Biochem Biophys Res Commun (2000) 0.96
Differential regulation of IgA production by TGF-beta and IL-5: TGF-beta induces surface IgA-positive cells bearing IL-5 receptor, whereas IL-5 promotes their survival and maturation into IgA-secreting cells. Cell Immunol (1992) 0.95
Characterization of the human IL-5 receptors on eosinophils. Cell Immunol (1991) 0.95
Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice. Life Sci (1993) 0.94
Cytokines involved in B-cell differentiation and their sites of action. Proc Soc Exp Biol Med (1997) 0.93
Regulatory effect of anti-interleukin-5 monoclonal antibody on intestinal worm burden in a primary infection with strongyloides venezuelensis in mice. Int J Parasitol (1994) 0.93
Multiple cerebral arteriovenous malformations (AVMs) associated with spinal AVM. Acta Neurochir (Wien) (1999) 0.92
Defective IL-5-receptor-mediated signaling in B cells of X-linked immunodeficient mice. Int Immunol (1995) 0.90
Cross-resistance between Strongyloides venezuelensis and S. ratti in mice. J Helminthol (1995) 0.89
Role of IL-5 in IL-2-induced eosinophilia. In vivo and in vitro expression of IL-5 mRNA by IL-2. J Immunol (1990) 0.89
TWEAK/Fn14 pathway promotes a T helper 2-type chronic colitis with fibrosis in mice. Mucosal Immunol (2013) 0.88
Molecular characterization of the beta chain of the murine interleukin 5 receptor. Int Immunol (1991) 0.86
Signal transduction through interleukin-5 receptors. Cold Spring Harb Symp Quant Biol (1989) 0.85
Rapid development of murine AIDS is dependent of signals provided by CD54 and CD11a. J Immunol (1995) 0.85
Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition. Int Immunol (2001) 0.85
Critical proline residues of the cytoplasmic domain of the IL-5 receptor alpha chain and its function in IL-5-mediated activation of JAK kinase and STAT5. Int Immunol (1996) 0.84
Significance of elevated thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex in the acute stage of nontraumatic subarachnoid hemorrhage. Neurosurgery (1994) 0.83
Comparative analysis of the kinetics of binding and internalization of IL-5 in murine IL-5 receptors of high and low affinity. J Immunol (1993) 0.81
Distribution of mouse interferon-beta in normal and brain tumour-bearing mice. Acta Neurochir (Wien) (1991) 0.80
Increased expression of atrial myosin light chain 1 in the overloaded human left ventricle: possible expression of fetal type myocytes. Int J Cardiol (1992) 0.80
Comparison of ES cell fate in sandwiched aggregates and co-cultured aggregates during blastocyst formation by monitored GFP expression. Mol Reprod Dev (1999) 0.80
Role of interleukin-5 in local accumulation of eosinophils in mouse allergic peritonitis. Int Arch Allergy Appl Immunol (1991) 0.80
Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride. Neurosurgery (1993) 0.80
Anxiolytic activity of SC-48274 compared with those of buspirone and diazepam in experimental anxiety models. Jpn J Pharmacol (1993) 0.79
Maintenance of CD5+ B cells at an early developmental stage by interleukin-5: evidence from immunoglobulin gene usage in interleukin-5 transgenic mice. DNA Cell Biol (1993) 0.79
Functional analysis of thymic B cells. Immunobiology (1994) 0.79
Interleukin-5: an overview. Cancer Treat Res (1995) 0.79
Novel intronic polymorphisms in the presenilin-2 gene and a case-control association study of Alzheimer's disease. Psychiatry Clin Neurosci (1999) 0.79
Murine interleukin 5 receptor isolated by immunoaffinity chromatography: comparison of determined N-terminal sequence and deduced primary sequence from cDNA and implication of a role of the intracytoplasmic domain. Int Immunol (1991) 0.79
Interleukin 5 activity in sera from patients with eosinophilia. Br J Haematol (1990) 0.79
IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma. J Viral Hepat (2011) 0.79
The murine interleukin-5 receptor alpha-subunit gene: characterization of the gene structure and chromosome mapping. DNA Cell Biol (1994) 0.79
Increased expression and regional differences of atrial myosin light chain 1 in human ventricles with old myocardial infarction. Analyses using two monoclonal antibodies. Circulation (1992) 0.78
Demonstration of a cross-talk between IL-2 and IL-5 in phosphorylation of IL-2 and IL-5 receptor beta chains. Int Immunol (1996) 0.78
Functional dissection of the cytoplasmic subregions of the interleukin-5 receptor alpha chain in growth and immunoglobulin G1 switch recombination of B cells. Immunology (2001) 0.78
Satiety function of neurons containing a CCK-like substance in the dorsal parabrachial nucleus. Physiol Behav (1990) 0.78
Cytokine receptors on Ly-1 B cells. IL-5 and its receptor system. Ann N Y Acad Sci (1992) 0.78
Novel monoclonal antibodies specific for human cardiac myosin light-chain 1: useful tools for analysis of normal and pathological hearts. J Histochem Cytochem (1993) 0.78
Localization of the gene encoding the alpha subunit of human interleukin-5 receptor (IL5RA) to chromosome region 3p24-3p26. Genomics (1992) 0.77
Isolated oculomotor nerve palsy following midbrain infarction. Clin Neurol Neurosurg (1994) 0.77
The xid mutation plays an important role in delayed development of murine acquired immunodeficiency syndrome. Int Immunol (1997) 0.77
Occlusion of internal carotid artery and formation of anterior communicating artery aneurysm in cervicocephalic fibromuscular dysplasia--follow-up case report. Neurol Med Chir (Tokyo) (1994) 0.77
Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) can induce differentiation of chronic B cell leukemia expressing the alpha subunit of IL-3 and GM-CSF receptor. Int Arch Allergy Immunol (1996) 0.76
Role of the interleukin 5 receptor system in hematopoiesis: molecular basis for overlapping function of cytokines. Bioessays (1992) 0.76
Neurotoxicity and pharmacokinetics of intrathecal perfusion of ACNU in dogs. Cancer Res (1990) 0.76
Mechanism of eosinophil infiltration in the patient with subcutaneous angioblastic lymphoid hyperplasia with eosinophilia (Kimura's disease). Mechanism of eosinophil chemotaxis mediated by candida antigen and IL-5. Int Arch Allergy Immunol (1994) 0.76
Biochemical and functional characterization of soluble form of IL-5 receptor alpha (sIL-5R alpha). Development of ELISA system for detection of sIL-5R alpha. J Immunol Methods (1994) 0.75
Primary brainstem hemorrhage in a child: usefulness of auditory brainstem response (ABR). Neuropediatrics (1984) 0.75
[Intracranial calcification on computerized tomography in childhood: classification and its clinical value]. No To Hattatsu (1983) 0.75
[Intrathecal perfusion of ACNU neurotoxicity and intrathecal pharmacokinetics in dogs]. No Shinkei Geka (1989) 0.75
[Epileptic children and swimming]. No To Hattatsu (1983) 0.75
[Angiosarcoma of the liver and pineal region]. No Shinkei Geka (1988) 0.75
[Prevention of decubitus ulcer in stroke patients]. Kango Gijutsu (1986) 0.75
Effect of YM 881 (SMANCS) in rats bearing intracerebrally implanted 9L glioma. Gan To Kagaku Ryoho (1991) 0.75
[A case of acute pancreatitis with hyperlipemia during pregnancy (author's transl)]. Nihon Shokakibyo Gakkai Zasshi (1979) 0.75
[Venous angioma with an arterial component and an associated aneurysm. Case report]. Neurol Med Chir (Tokyo) (1988) 0.75
Antiproliferative effect of YM881 (SMANCS) on glioma cells in vitro. Anticancer Res (1992) 0.75
[Antitumor effect of a new anthracycline derivative, MX2, against human glioma cells]. Gan To Kagaku Ryoho (1989) 0.75
Behavioral disorders in Japanese epileptic children. Folia Psychiatr Neurol Jpn (1983) 0.75
Present status of medical care for child epilepsy--from a pediatric clinic of university hospital. Folia Psychiatr Neurol Jpn (1979) 0.75
Serial computed tomographic studies of pineal region tumor treated by irradiation. Kurume Med J (1979) 0.75
Compliance in epileptic children in Japan. Epilepsy Res Suppl (1988) 0.75
[Autism. Discussion: from the standpoint of pediatrics]. No To Hattatsu (1989) 0.75
[Noncompliance in the treatment of epileptic children]. Fukuoka Igaku Zasshi (1983) 0.75
MR arteriography using an implantable port system: a new method in assessing perfusion abnormalities during hepatic arterial infusion chemotherapy. J Comput Assist Tomogr (2000) 0.75